Steviol Glycoside Market Size, Share, Growth, and Industry Analysis, By Type (Stevioside,Steviolbioside,Rubusoside,Dulcoside A,Rebaudioside A,Rebaudioside B,Rebaudioside C,Rebaudioside D,Rebaudioside E,Rebaudioside F), By Application (Food & Beverages,Pharmaceutical,Chemical Industry,Other), Regional Insights and Forecast to 2035

Steviol Glycoside Market Overview

The global Steviol Glycoside Market is forecast to expand from USD 555.5 million in 2026 to USD 586.39 million in 2027, and is expected to reach USD 904.07 million by 2035, growing at a CAGR of 5.56% over the forecast period.

The global Steviol Glycoside Market represents a fast-growing segment within the natural sweetener industry, driven by increasing demand for zero-calorie and plant-based sugar alternatives. Steviol glycosides, extracted from Stevia rebaudiana leaves, are approximately 30 to 320 times sweeter than sucrose depending on concentration and purity. Globally, more than 90 countries have approved steviol glycosides for food and beverage applications. The total market volume is estimated at around 25,000 to 30,000 metric tons annually, with food and beverages accounting for 60% of total usage. Over 1,000 new stevia-based products were launched worldwide between 2023 and 2025.

In the U.S. steviol glycoside market, steviol glycosides are approved as Generally Recognized as Safe (GRAS) for consumption in foods and beverages. The United States accounts for approximately 15% to 25% of the global market share. Over 150 beverage SKUs and more than 60 snack product lines in the country incorporate stevia-derived glycosides. The U.S. produces roughly 3,000 metric tons of purified steviol glycoside annually, with over 80% purity levels achieved through advanced filtration and crystallization. Around 42% of American consumers actively seek natural, sugar-free products, which directly supports growing steviol glycoside consumption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% rise in consumer demand for natural sweeteners in packaged food formulations.
• Major Market Restraint: 22% higher production cost versus synthetic high-intensity sweeteners.
• Emerging Trends: 45% of new beverage products in 2024 featured stevia-based blends.
• Regional Leadership: Asia-Pacific holds 38% of global consumption share.
• Competitive Landscape: Top 2 companies represent nearly 30% of global capacity.
• Market Segmentation: Food and beverages make up about 65% of total consumption.
• Recent Development: 55% of new R&D projects in 2023–2024 focused on enzyme-modified glycosides such as Reb M and Reb D.

Steviol Glycoside Market Latest Trends

The Steviol Glycoside Market Report identifies biotechnological innovation as the key trend shaping global production. Manufacturers are transitioning toward enzymatic and fermentation-based production of high-purity Rebaudioside M and Rebaudioside D. More than 35 patented technologies have been introduced globally since 2023, improving conversion yields by 10% to 20% per production cycle. Surveys show that 42% of new health beverages launched in 2024 carried “sweetened with stevia” labeling. The Steviol Glycoside Market Analysis shows that blended glycosides (e.g., Reb A + Reb D combinations) now represent 28% of all tabletop and beverage formulations. Across major food brands, sugar content has been reduced by 5% to 12% in bakery and dairy lines through stevia integration. Over 12 metric tons per month of steviol glycoside are utilized in dairy-alternative and low-sugar beverage production. Regulatory approvals in the European Union and Asia-Pacific for 11 different steviol glycosides have enhanced product flexibility. Approximately 70% of glucosylated steviol glycoside (GSG) output in 2025 is expected to serve beverage manufacturers. Collectively, these Steviol Glycoside Market Trends demonstrate an industry driven by sustainable bioconversion, flavor improvement, and broad consumer acceptance of stevia-derived sweeteners.

Steviol Glycoside Market Dynamics

DRIVER

"Rising demand for natural and clean-label sweeteners"

Over 60% of food manufacturers globally are reformulating products to include natural sweeteners. In North America alone, 58% of consumers prefer natural sweeteners to artificial alternatives. The share of beverages using steviol glycosides rose from 35% in 2022 to 45% in 2024. Additionally, 537 million adults worldwide are affected by diabetes, motivating sugar reduction. Steviol glycosides, offering zero calories and no glycemic response, fulfill this demand. 

RESTRAINT

"High production and purification costs"

Processing steviol glycosides involves extraction, filtration, and crystallization steps, leading to 20–30% purification losses during conversion. Chromatography and drying processes add 15–25% cost overheads, making stevia 18–25% costlier per sweetness unit than synthetic alternatives like aspartame or sucralose. Leaf yield variability—due to drought or pests—can reduce raw material availability by 10–15% annually.

OPPORTUNITY

"Growth of fermentation and enzyme-based production"

Between 2023 and 2024, over 40 R&D institutions and ingredient producers filed enzyme-engineering patents converting stevioside to Reb M, Reb D, and Reb I with 12–18% higher yields. About 25% of projected production expansion by 2025 will rely on fermentation technologies. These methods reduce raw material waste by 10% and cut downstream processing costs by 15%. High-purity Reb M (98%) is already available through bioconversion lines. 

CHALLENGE

"Taste profile and regulatory harmonization"

Despite high sweetness, steviol glycosides can cause bitterness and aftertaste at concentrations above 0.5%. Sensory tests indicate 18% of consumers perceive mild licorice notes in high-intensity stevia blends. Global regulation remains fragmented: only 5 to 9 glycosides are approved in certain jurisdictions. Labeling inconsistencies across 35 countries—such as “E960” versus “steviol glycosides”—confuse consumers. From 2022 to 2024, eight countries issued import alerts or restrictions on unapproved glycoside forms. 

Steviol Glycoside Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Stevioside: The most abundant natural glycoside, representing 70–80% of crude leaf extracts. It has a relative sweetness of 150–250 times that of sugar and forms the base material for downstream conversion.

The Stevioside segment is valued at USD 110.51 million in 2025, accounting for 21% share, with a CAGR of 5.6%, driven by its widespread use in food and beverage formulations.

Top 5 Dominant Countries in Stevioside

• China: Market size USD 33.15 million, share 30%, CAGR 5.7%, supported by large-scale cultivation and manufacturing.
• United States: Valued at USD 26.52 million, share 24%, CAGR 5.6%, strong beverage industry adoption.
• India: Market size USD 18.87 million, share 17%, CAGR 5.8%, growing demand in packaged foods.
• Germany: Valued at USD 16.57 million, share 15%, CAGR 5.5%, driven by sugar substitution.
• Brazil: Market size USD 15.40 million, share 14%, CAGR 5.6%, expansion in confectionery.

Steviolbioside: Steviolbioside is a minor glycoside found in Stevia rebaudiana leaves, typically representing less than 1% w/w of total leaf content. Despite its limited natural presence, it offers moderate sweetness levels with reduced bitterness, making it useful in blended formulations.

The Steviolbioside market is USD 47.36 million in 2025, holding 9% share, projected at CAGR of 5.4%, driven by niche applications in low-calorie sweeteners.

Top 5 Dominant Countries in Steviolbioside

• China: Valued at USD 12.80 million, share 27%, CAGR 5.5%, benefiting from large extraction facilities.
• United States: Market size USD 10.88 million, share 23%, CAGR 5.3%, niche use in beverages.
• Japan: Valued at USD 8.05 million, share 17%, CAGR 5.4%, growing functional food demand.
• Germany: Market size USD 7.11 million, share 15%, CAGR 5.3%, steady growth in diet products.
• India: Valued at USD 6.61 million, share 14%, CAGR 5.4%, rising health-conscious population.

Rubusoside: Rubusoside occurs naturally in Stevia rebaudiana leaves in concentrations of 0.5% to 2%, depending on leaf maturity and cultivar. It exhibits sweetness approximately 100 to 150 times that of sucrose and is widely valued for its solubilizing properties in pharmaceutical applications.

The Rubusoside segment accounts for USD 36.84 million in 2025, capturing 7% share, and is set to grow at CAGR of 5.2%, supported by its role as a solubilizer in pharmaceuticals.

Top 5 Dominant Countries in Rubusoside

• China: Market size USD 12.16 million, share 33%, CAGR 5.3%, strong supply chain.
• United States: Valued at USD 8.09 million, share 22%, CAGR 5.1%, demand in drug formulations.
• Japan: Market size USD 6.63 million, share 18%, CAGR 5.2%, functional foods integration.
• Germany: Valued at USD 5.16 million, share 14%, CAGR 5.1%, pharma-based adoption.
• India: Market size USD 4.80 million, share 13%, CAGR 5.3%, nutraceutical applications rising.

Dulcoside A: Dulcoside A constitutes approximately 0.5% to 1% of total glycoside content in dried stevia leaves. It provides mild sweetness—about 30 to 60 times sweeter than sucrose—and has a clean flavor profile with minimal aftertaste.

The Dulcoside A segment is valued at USD 38.96 million in 2025, representing 7.4% share of the global market, and forecasted to grow at a CAGR of 4.9% until 2034, driven by its limited but niche food usage.

Top 5 Major Dominant Countries in the Dulcoside A Segment

• United States: Valued at USD 8.12 million in 2025, with 20.8% share and CAGR of 5.0%, driven by health-focused beverage applications.
• China: Estimated at USD 7.94 million in 2025, holding 20.3% share and CAGR of 4.8%, supported by extraction and cost advantages.
• Germany: Germany’s Dulcoside A market is USD 6.25 million in 2025, with 16% share and CAGR of 5.1%, reflecting rising demand in sugar-reduced foods.
• Japan: Valued at USD 5.24 million in 2025, capturing 13.4% share with CAGR of 4.7%, driven by preference for blended sweeteners.
• India: Estimated at USD 4.71 million in 2025, with 12.1% share and CAGR of 5.3%, as urban dietary health adoption rises.

Rebaudioside A: One of the most commercially important glycosides, contributing 8–12% of total purified product blends. It provides superior sweetness with reduced bitterness, used in 80% of global stevia-based beverages.

Rebaudioside A dominates with USD 142.09 million in 2025, representing 27% share, and is expected to grow at a CAGR of 6.3% until 2034, driven by its clean taste and mass adoption in beverages.

Top 5 Major Dominant Countries in the Rebaudioside A Segment

• United States: Leading with USD 34.54 million in 2025, securing 24.3% share and CAGR of 6.5%, propelled by soda and energy drink makers.
• China: Valued at USD 30.87 million in 2025, with 21.7% share and CAGR of 6.2%, leveraging large-scale manufacturing.
• Germany: Germany’s segment is USD 25.24 million in 2025, holding 17.8% share with CAGR of 6.1%, tied to regulatory sugar reformulation.
• Japan: At USD 22.12 million in 2025, with 15.5% share and CAGR of 6.0%, driven by strong beverage integration.
• India: India’s market size is USD 19.32 million in 2025, with 13.6% share and CAGR of 6.4%, fueled by packaged beverage adoption.

Rebaudioside B: Rebaudioside B is found in trace quantities in Stevia rebaudiana leaves, typically at less than 1% of total glycoside content. While not as sweet as Reb A, it contributes to the complexity and depth of multi-component blends.

The Rebaudioside B segment stands at USD 45.98 million in 2025, holding 8.7% share, and forecasted to grow at CAGR of 5.1%, largely used in customized sweetener blends.

Top 5 Major Dominant Countries in the Rebaudioside B Segment

• United States: Valued at USD 10.05 million in 2025, with 21.8% share and CAGR of 5.3%, supported by blending in F&B applications.
• China: Market size USD 9.42 million in 2025, 20.5% share and CAGR 5.0%, benefiting from cost-efficient production.
• Japan: Valued at USD 8.02 million in 2025, share 17.4% and CAGR 5.0%, for functional foods.
• Germany: Germany’s segment at USD 7.56 million in 2025, with 16.4% share and CAGR of 5.2%, demand from clean-label foods.
• India: India valued at USD 6.93 million in 2025, holding 15.1% share and CAGR of 5.4%, driven by urban dietary adoption.

Rebaudioside C: Rebaudioside C makes up 1–2% of the glycoside profile in stevia leaves and is approximately 40–60 times sweeter than sucrose. It has a softer sweetness curve and is used to moderate flavor intensity in formulations dominated by Reb A or stevioside.

Rebaudioside C is estimated at USD 48.09 million in 2025, accounting for 9.1% share, expected to grow at CAGR of 5.6%, due to its favorable taste profile for F&B.

Top 5 Major Dominant Countries in the Rebaudioside C Segment

• United States: Market size USD 10.83 million in 2025, with 22.5% share and CAGR of 5.7%, demand from low-calorie drinks.
• China: Valued at USD 9.95 million in 2025, with 20.7% share and CAGR of 5.6%, supported by extraction technologies.
• Germany: Germany at USD 8.24 million in 2025, 17.1% share, CAGR of 5.5%, reflecting regulatory-driven demand.
• Japan: Japan valued at USD 7.44 million in 2025, 15.5% share, CAGR of 5.4%, driven by sweetener blending.
• India: India at USD 6.93 million in 2025, 14.2% share, CAGR of 5.7%, rising in packaged foods.

Rebaudioside D: Rebaudioside D is an emerging next-generation steviol glycoside, present in trace amounts (<1%) in natural leaves but now produced enzymatically for large-scale use. Biotechnological conversion processes have achieved production yields of 60–80% purity in pilot operations, allowing Reb D to form 5–8% of commercial stevia blends.

Rebaudioside D holds USD 52.62 million in 2025, representing 10% share, and is projected to grow at CAGR of 6.0%, favored for its superior sweetness profile in beverages.

Top 5 Major Dominant Countries in the Rebaudioside D Segment

• United States: Valued at USD 11.74 million in 2025, with 22.3% share and CAGR of 6.2%, driven by soft drink giants.
• China: Market size USD 10.54 million in 2025, 20% share and CAGR 6.0%, with supply strength.
• Germany: Germany at USD 9.09 million in 2025, share 17.3%, CAGR of 5.9%, R&D-driven adoption.
• Japan: Japan’s market at USD 8.24 million in 2025, share 15.7%, CAGR 5.8%, premium natural sweeteners.
• India: Valued at USD 7.55 million in 2025, share 14.4%, CAGR 6.1%, adoption in packaged beverages.

Rebaudioside E: Rebaudioside E exists in very small quantities in natural stevia leaves, typically under 1% of the glycoside profile. It is commonly produced via enzyme modification of stevioside or Rebaudioside A to improve overall sweetness balance. Reb E contributes clean, mild sweetness with a short finish, making it suitable for carbonated beverages and flavor blends.

Rebaudioside E is valued at USD 33.68 million in 2025, holding 6.4% share, forecasted CAGR of 5.0%, supported by blended sweetener formulations.

Top 5 Major Dominant Countries in the Rebaudioside E Segment

• United States: Valued at USD 7.55 million in 2025, share 22.4%, CAGR 5.1%, niche blended applications.
• China: Market size USD 6.94 million in 2025, share 20.6%, CAGR 5.0%, driven by manufacturing leadership.
• Germany: Germany at USD 6.05 million in 2025, share 18%, CAGR 5.0%, premium categories.
• Japan: Valued at USD 5.39 million in 2025, share 16%, CAGR 4.9%, specialty consumption.
• India: India’s market size USD 4.82 million in 2025, share 14.3%, CAGR 5.2%, expanding packaged food sector.

Rebaudioside F: Rebaudioside F is the rarest naturally occurring steviol glycoside, typically comprising less than 0.5% of total leaf glycoside content. Despite its low natural abundance, it has gained attention for its unique stability in acidic environments, maintaining sweetness integrity at pH levels as low as 3.0. Its sweetness ranges between 150 and 200 times that of sucrose, with a clean taste profile and minimal lingering aftertaste.

The Rebaudioside F segment is estimated at USD 22.82 million in 2025, representing 4.3% share, and expected to grow at CAGR of 4.7%, driven by niche uses in sweetener blends.

Top 5 Major Dominant Countries in the Rebaudioside F Segment

• United States: Valued at USD 5.11 million in 2025, share 22.4%, CAGR 4.8%, niche beverage blends.
• China: Market size USD 4.61 million in 2025, share 20.2%, CAGR 4.7%, supported by production scale.
• Germany: Germany at USD 4.02 million in 2025, share 17.6%, CAGR 4.6%, diversification in sweeteners.
• Japan: Japan valued at USD 3.56 million in 2025, share 15.6%, CAGR 4.5%, used in specialty foods.
• India: India’s segment at USD 3.22 million in 2025, share 14.1%, CAGR 4.9%, gradual packaged food adoption.

BY APPLICATION

Food & Beverages: This segment dominates with 65% of global demand. Over 300 new beverage formulations adopted stevia-derived sweeteners between 2023 and 2025. Sugar reduction in dairy and bakery items has improved formulation competitiveness by 10–15%.

The Food & Beverages application dominates with USD 315.74 million in 2025, representing 60% share, and is expected to grow at a CAGR of 6.0% until 2034, fueled by increasing demand for low-calorie natural sweeteners.

Top 5 Major Dominant Countries in the Food & Beverages Application

• United States: Valued at USD 71.87 million in 2025, with 22.8% share and CAGR of 6.2%, supported by strong demand from soda and energy drink manufacturers.
• China: Market size USD 63.46 million in 2025, 20.1% share, CAGR of 6.0%, benefiting from beverage industry expansion and large-scale production.
• Germany: Germany valued at USD 50.44 million in 2025, share 16%, CAGR of 5.9%, driven by sugar reformulation policies.
• India: India’s Food & Beverages segment is USD 46.48 million in 2025, 14.7% share, CAGR 6.3%, led by packaged drinks and urban adoption.
• Brazil: Brazil valued at USD 40.96 million in 2025, share 13%, CAGR 6.1%, supported by carbonated drink and confectionery demand.

Pharmaceutical: Accounts for 15–18% of market volume. Used in oral tablets, syrups, and nutraceuticals as taste-masking and non-caloric sweetening agents. Over 40 formulations in Asia and North America now contain steviol glycoside as an excipient.

The Pharmaceutical application is estimated at USD 105.25 million in 2025, accounting for 20% share, and forecasted to expand at CAGR of 5.5%, driven by rising use in diabetes care and therapeutic formulations.

Top 5 Major Dominant Countries in the Pharmaceutical Application

• United States: Valued at USD 24.71 million in 2025, share 23.5%, CAGR of 5.6%, supported by high diabetes prevalence.
• China: China’s pharmaceutical segment at USD 21.57 million in 2025, share 20.5%, CAGR 5.5%, driven by large pharma sector integration.
• Germany: Market size USD 18.94 million in 2025, share 18%, CAGR 5.4%, increasing therapeutic sweetener adoption.
• Japan: Japan valued at USD 16.84 million in 2025, share 16%, CAGR 5.3%, driven by functional medicine applications.
• India: India’s segment USD 14.74 million in 2025, share 14%, CAGR 5.7%, rising healthcare demand.

Chemical Industry: Represents 5–7% of total consumption. Used as an intermediate in fine chemicals and biodegradable surfactants.

The Chemical Industry application stands at USD 63.15 million in 2025, capturing 12% share, with CAGR of 4.8%, as steviol glycosides find usage in biochemistry, specialty formulations, and intermediates.

Top 5 Major Dominant Countries in the Chemical Industry Application

• United States: Valued at USD 13.54 million in 2025, share 21.5%, CAGR 4.9%, supported by biochemical research adoption.
• China: Market size USD 12.66 million in 2025, share 20%, CAGR 4.8%, benefiting from industrial-scale extraction.
• Germany: Germany valued at USD 11.05 million in 2025, share 17.5%, CAGR 4.7%, expanding in specialty chemicals.
• India: India at USD 9.79 million in 2025, share 15.5%, CAGR 5.0%, supported by pharma-linked chemical sector.
• Brazil: Brazil valued at USD 8.81 million in 2025, share 14%, CAGR 4.6%, gradual expansion in specialty industries.

Other Applications: Covers 10–12% of usage, mainly in cosmetics, oral care, and hygiene products. In 2024, 25 oral care SKUs were launched globally with stevia-based sweeteners replacing sorbitol and saccharin.

The “Other” applications segment, including personal care and niche uses, is valued at USD 42.10 million in 2025, contributing 8% share, and projected to grow at CAGR of 4.5%, driven by specialty consumption.

Top 5 Major Dominant Countries in the Other Application

• United States: Market valued at USD 9.28 million in 2025, share 22%, CAGR 4.6%, used in natural cosmetics and supplements.
• China: Valued at USD 8.42 million in 2025, share 20%, CAGR 4.5%, niche adoption in nutraceuticals.
• Japan: Market size USD 7.16 million in 2025, share 17%, CAGR 4.4%, specialty functional products.
• Germany: Germany valued at USD 6.31 million in 2025, share 15%, CAGR 4.5%, used in personal care formulations.
• India: India’s segment USD 5.26 million in 2025, share 12.5%, CAGR 4.7%, niche packaged consumer goods.

Steviol Glycoside Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds about 25% of global market volume, driven by strong demand in the U.S. and Canada. The United States alone contributes 80% of regional consumption. In 2024, more than 3,500 metric tons of steviol glycoside were utilized in beverage and snack production. Approximately 30% of global production capacity for high-purity stevia is based in North America. Consumer surveys reveal that 54% of U.S. adults regularly purchase low-sugar or stevia-sweetened products. The region’s market growth is supported by a mature health food industry and expanding use in dietary supplements.

The North America Steviol Glycoside market is valued at USD 157.87 million in 2025, holding 30% share, and is projected to grow at a CAGR of 5.8%, driven by strong demand in beverages and pharmaceuticals.

North America – Major Dominant Countries in the Steviol Glycoside Market

• United States: Market size USD 102.61 million in 2025, share 65%, CAGR 5.9%, driven by high natural sweetener adoption in soft drinks and packaged foods.
• Canada: Valued at USD 28.42 million in 2025, share 18%, CAGR 5.7%, supported by sugar-reduction initiatives in food production.
• Mexico: Market size USD 19.44 million in 2025, share 12.3%, CAGR 5.8%, driven by sweetener use in beverages.
• Cuba: Valued at USD 4.73 million in 2025, share 3%, CAGR 5.6%, limited but growing food processing sector.
• Dominican Republic: Market size USD 2.93 million in 2025, share 1.9%, CAGR 5.5%, small but expanding beverage demand.

EUROPE

Europe represents roughly 20% of total global steviol glycoside consumption. Regulatory flexibility allowing combinations of up to 11 glycosides per product has accelerated adoption. Germany, France, and the U.K. collectively account for 60% of European demand. Over 120 new stevia-based food and beverage products launched in 2023–2024. Approximately 64% of European consumers recognize “stevia” as a natural sweetener, and government sugar-reduction pledges aim for a 10% reduction by 2025, reinforcing usage across the continent.

The Europe Steviol Glycoside market is valued at USD 131.56 million in 2025, representing 25% share, with CAGR of 5.4%, led by regulatory encouragement for natural sweeteners and demand from confectionery.

Europe – Major Dominant Countries in the Steviol Glycoside Market

• Germany: Market size USD 34.21 million in 2025, share 26%, CAGR 5.5%, leading due to reformulation initiatives.
• United Kingdom: Valued at USD 26.31 million in 2025, share 20%, CAGR 5.3%, supported by anti-obesity programs.
• France: Market size USD 22.36 million in 2025, share 17%, CAGR 5.4%, growing health-conscious consumer base.
• Italy: Valued at USD 19.73 million in 2025, share 15%, CAGR 5.2%, confectionery and beverages drive growth.
• Spain: Market size USD 15.79 million in 2025, share 12%, CAGR 5.3%, expanding packaged food industry.

ASIA-PACIFIC

Asia-Pacific leads with 38% of global consumption. Japan, China, India, and South Korea are major contributors. China produces over 45% of the world’s stevia leaf extracts and operates 20 major extraction facilities. Japan remains a consistent consumer, with 40% of alternative sweetener usage attributed to stevia-based products. India, Vietnam, and Thailand together account for 25% of global cultivation acreage, producing over 10,000 metric tons of leaves annually. In 2024, 300 new beverage and dairy reformulations in the region used steviol glycoside blends.

Asia dominates with the largest market size of USD 210.50 million in 2025, securing 40% share, and expanding at a CAGR of 5.9%, led by high production capacity and strong adoption in food and pharma.

Asia – Major Dominant Countries in the Steviol Glycoside Market

• China: Market size USD 84.20 million in 2025, share 40%, CAGR 6.0%, the largest producer and consumer base.
• India: Valued at USD 47.52 million in 2025, share 22.6%, CAGR 6.1%, rising packaged beverage demand.
• Japan: Market size USD 36.26 million in 2025, share 17.2%, CAGR 5.8%, functional foods and pharma usage.
• South Korea: Valued at USD 25.26 million in 2025, share 12%, CAGR 5.9%, strong in health-conscious beverages.
• Indonesia: Market size USD 17.26 million in 2025, share 8.2%, CAGR 5.7%, sweetener integration in mass-market products.

MIDDLE EAST & AFRICA

MEA accounts for 8% of the global market. The largest consumers are Saudi Arabia, the UAE, and South Africa, representing 70% of regional demand. About 50 beverage SKUs in the region now use stevia-based sweeteners. Local production remains limited, with reliance on imports subject to 5–12% tariffs. In 2024, adoption increased by 15% year-on-year as consumer awareness of sugar-related health issues grew across GCC and African countries.

The MEA Steviol Glycoside market stands at USD 26.31 million in 2025, with 5% share, and projected CAGR of 5.2%, supported by sugar reduction policies and demand for natural sweeteners in urban areas.

Middle East and Africa – Major Dominant Countries in the Steviol Glycoside Market

• United Arab Emirates: Market size USD 6.31 million in 2025, share 24%, CAGR 5.3%, premium beverage adoption.
• Saudi Arabia: Valued at USD 5.78 million in 2025, share 22%, CAGR 5.4%, driven by sugar reform initiatives.
• South Africa: Market size USD 5.26 million in 2025, share 20%, CAGR 5.1%, confectionery and processed food expansion.
• Egypt: Valued at USD 4.21 million in 2025, share 16%, CAGR 5.0%, steady growth from urban food processing.
• Nigeria: Market size USD 3.15 million in 2025, share 12%, CAGR 5.2%, rising consumption of sweetened beverages.

List of Top Steviol Glycoside Companies

• Sunrise Nutrachem Group
• Daepyung
• GL Stevia
• Merisant
• PureCircle
• Morita Kagaku Kogyo
• Cargill
• Tate & Lyle

PureCircle: Holds 16–18% of global production capacity, supplying over 25% of stevia-based beverage formulations.

Tate & Lyle: Represents 12–14% of global volume, active in more than 50 countries across the food & beverage market.

Investment Analysis and Opportunities

Investment in the Steviol Glycoside Market is accelerating through biotechnology partnerships and capacity expansions. Between 2023 and 2024, capital expenditure in fermentation-based production exceeded 30 million USD globally. Joint ventures between ingredient manufacturers have pooled over 10–15 million USD for facility upgrades in Asia and North America. By 2025, 40% of new global capacity will originate from enzyme-driven or fermentation technologies. 

New Product Development

Innovation in the Steviol Glycoside Industry focuses on improving taste and stability. Between 2023 and 2025, more than 10 high-purity glycoside products were launched with purity levels between 98% and 99%. Microencapsulation technologies have enhanced dissolution speed by 15%, reducing aftertaste intensity. Dual-sweetener blends combining stevia with monk fruit in a 70:30 ratio now represent 12 new product lines globally. Formulation innovation has yielded improved stability under acidic conditions, allowing consistent taste at pH levels as low as 3.0. Particle engineering has reduced dust loss during packaging by 8%, improving yield and handling efficiency. 

Five Recent Developments

• 2023: A major producer launched a 95% pure Rebaudioside M variant targeting functional beverages.
• 2023: A global partnership achieved 12% higher enzyme conversion yield in steviol glycoside synthesis.
• 2024: European regulation expanded approval to 11 glycosides, enabling flexible formulation across all food categories.
• 2024: A Chinese extraction facility added 2,000 metric tons per year of new capacity, increasing global supply stability.
• 2025: Three ingredient manufacturers co-developed encapsulated stevia compounds reducing bitterness by 30% in high-intensity formulations.

Report Coverage of Steviol Glycoside Market

The Steviol Glycoside Market Research Report provides comprehensive coverage of market size, share, segmentation, and competitive outlook across global regions. It includes analysis of 10 steviol glycoside types (Stevioside, Steviolbioside, Rubusoside, Dulcoside A, and Rebaudioside A–F) and four key application areas (Food & Beverages, Pharmaceutical, Chemical, and Others). 

Steviol Glycoside Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 555.5 Million in 2026
Market Size Value By	USD 904.07 Million by 2035
Growth Rate	CAGR of 5.56% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Stevioside Steviolbioside Rubusoside Dulcoside A Rebaudioside A Rebaudioside B Rebaudioside C Rebaudioside D Rebaudioside E Rebaudioside F By Application : Food & Beverages Pharmaceutical Chemical Industry Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample